Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Cancer. 2008 Nov 1;113(9):2488–2495. doi: 10.1002/cncr.23854

Table 3.

Stratified analysis for CCND1, P53 R72P, and CDK6 by gender and age

Male Female Young Individual(Age ≤60) Old Individual (Age>60)

Control Case OR(95% CI) * Control Case OR(95% CI) * Control Case OR(95% CI) Control Case OR(95% CI)
CCND1 P241P 82 81 65 63 79 83 68 61
 GG 33 15 1 23 22 1 36 23 1 20 14 1
 AG 39 43 2.55(1.08-6.04) 30 27 0.85(0.36-2.04) 31 40 2.08(0.95-4.57) 38 30 0.97(0.38-2.49)
 AA 10 23 9.89(3.00-32.68) 12 14 0.84(0.29-2.48) 12 20 2.75(1.02-7.42) 10 17 2.67(0.83-8.58)
 Dominant 3.51(1.56-7.93) 0.85(0.38-1.92) 2.26(1.09-4.71) 1.30(0.54-3.14)
 Recessive 5.37(1.94-14.88) 0.92(0.36-2.40) 1.83(0.76-4.44) 2.72(1.00-7.36)
P for trend <0.0001 0.729 0.030 0.127

P53 R72P 77 61 60 49 73 64 64 46
 GG 37 36 1 31 26 1 33 36 1 35 26 1
 GC 30 20 0.65(0.28-1.50) 23 22 1.15(0.50-2.64) 28 26 1.06(0.48-2.33) 25 16 0.59(0.24-1.46)
 CC 10 5 0.63(0.17-2.42) 6 1 12 2 0.19(0.03-1.29) 4 4 0.83(0.13-5.42)
Dominant 0.65(0.30-1.41) 0.92(0.41-2.08) 0.85(0.40-1.81) 0.62(0.26-1.46)
Recessive 0.75(0.21-2.76) 0.19(0.03-1.22) 0.99(0.16-6.29)
P for trend 0.31 0.434 0.268 0.368

CDK6 3′UTR 80 77 62 52 75 75 67 54
 CC 46 54 1 35 32 1 43 57 1 38 29 1
 CT 29 20 0.64(0.29-1.43) 26 15 0.57(0.24-1.38) 29 15 0.44(0.19-0.98) 26 20 1.06(0.45-2.49)
 TT 5 3 0.72(0.12-4.13) 1 5 7.75(0.76-79.39) 3 3 0.68(0.12-3.95) 3 5 3.17(0.58-17.32)
Dominant 0.65(0.30-1.41) 0.78(0.34-1.78) 0.46(0.21-1.00) 1.23(0.54-2.78)
Recessive 0.84(0.15-4.77) 9.50(0.96-94.52) 0.89(0.16-5.05) 3.09(0.59-16.07)
P for trend 0.33 0.743 0.095 0.344
*

Adjusted by age, ethnicity, smoking status(never, former, and current), and alcohol use

Adjusted by age, gender, ethnicity, smoking status(never, former, and current), and alcohol use